Hermetica Superfood Encyclopedia
The Short Answer
Cassia tora seeds and leaves contain anthraquinones—principally chrysophanol, emodin, rhein, and obtusifolin—that exert antioxidant, hepatoprotective, and laxative effects by scavenging free radicals, upregulating hepatic antioxidant enzymes, and stimulating colonic motility. Preclinical data demonstrates that leaf ethyl acetate extracts contain up to 106.8 ± 2.8 mg/g dry weight quercetin equivalents of flavonoids, and seed anthraquinones inhibit aflatoxin B1 mutagenicity in the Ames test, though no human clinical trials have yet quantified these effects in controlled populations.
CategoryHerb
GroupSoutheast Asian
Evidence LevelPreliminary
Primary Keywordcassia tora benefits
Sickle Pod — botanical close-up
Health Benefits
**Antioxidant Protection**
Leaf extracts, particularly the ethyl acetate fraction (CtEA), provide 106.8 ± 2.8 mg/g dry weight quercetin equivalents of flavonoids including quercetin, kaempferol, and epicatechin that scavenge ABTS radicals dose-dependently between 0–25 µg/mL and protect erythrocyte membranes from H₂O₂-induced hemolysis.
**Hepatoprotection**
Anthraquinone aglycones—especially emodin and chrysophanol—upregulate hepatic catalase, superoxide dismutase, and glutathione peroxidase in ethanol-induced hepatotoxicity models in rats, reducing oxidative lipid peroxidation and supporting liver enzyme normalization.
**Constipation Relief**
The anthraquinone glycosides in Cassia tora seeds stimulate colonic peristalsis through irritant laxative mechanisms shared across the Cassia/Senna genus, a property central to their traditional use in Indonesian Jamu and Ayurveda for constipation and dyspepsia.
**Antimutagenic and Chemopreventive Activity**
Anthraquinone aglycones inhibit mutagenicity induced by aflatoxin B1, polycyclic aromatic hydrocarbons, and heterocyclic amines in Ames test bioassays, suggesting potential chemoprevention by intercepting DNA-reactive carcinogens.
**Anti-inflammatory Effects**
Flavonoids (quercetin, kaempferol, rutin) and anthraquinones modulate inflammatory pathways in vitro, with seed compounds including cassiaside, torachrysone, and obtusifolin demonstrating anti-inflammatory activity in preclinical models.
**Antimicrobial Activity**
Methanolic leaf extracts exhibit broad-spectrum antimicrobial activity against bacterial pathogens in vitro, consistent with their traditional Ayurvedic application in Dadhughnavati formulations for leprosy and ringworm caused by dermatophytic fungi.
**Hypolipidemic Effects**
Ethanolic seed extracts demonstrated lipid-lowering activity in Wistar rat models, reducing serum cholesterol and triglyceride levels through mechanisms likely linked to anthraquinone-mediated modulation of hepatic lipid metabolism.
Origin & History
Natural habitat
Cassia tora L. is native to tropical and subtropical Asia, including India, Indonesia, Southeast Asia, and parts of Africa, thriving in disturbed soils, roadsides, and wastelands at low to moderate elevations. It grows as an annual or short-lived perennial herb in warm, humid climates with well-drained soils, reaching up to one meter in height. The plant has been cultivated and wildcrafted across South and Southeast Asia for millennia, featuring prominently in Indonesian Jamu herbalism and Indian Ayurvedic practice.
“Cassia tora has been documented in Ayurvedic medicine for over two thousand years, referenced in classical texts for the treatment of leprosy, ringworm (tinea), skin disorders, flatulence, colic, constipation, cough, bronchitis, and cardiac complaints, with the formulation Dadhughnavati specifically citing it for antifungal dermatological use. In Indonesian traditional medicine (Jamu), the seeds and leaves are employed primarily for eye ailments—including inflammation and blurred vision attributed in traditional frameworks to liver heat—and as a mild laxative, reflecting the Jamu system's holistic approach linking ocular and hepatic function. The plant's common names 'coffee pod' and 'sickle pod' reflect its distinctive curved seed pods and historical use of roasted seeds as a coffee substitute in rural communities across Asia and Africa. Traditional preparations range from simple seed decoctions and poultices of crushed leaves applied topically for skin infections to more complex multi-herb Jamu and Ayurvedic formulas in which Cassia tora seeds contribute anthraquinone laxative and hepatoprotective properties.”Traditional Medicine
Scientific Research
The evidence base for Cassia tora consists entirely of in vitro cell culture studies and small animal experiments, with no published human randomized controlled trials identified as of the current research review. Preclinical studies include Comet assay data demonstrating reduced H₂O₂-induced DNA damage in isolated human lymphocytes, Ames test results showing inhibition of aflatoxin B1 mutagenicity, and rat models of ethanol-induced hepatotoxicity showing improved hepatic antioxidant enzyme profiles, but none of these studies report standardized sample sizes or confidence intervals sufficient for clinical extrapolation. Hypolipidemic activity was demonstrated in Wistar rats using ethanolic extracts, and antimicrobial activity was shown against bacterial species using leaf methanolic extracts in disc diffusion assays, though minimum inhibitory concentrations (MICs) and quantitative outcomes were not consistently reported. The overall evidence quality is low by clinical standards; the ingredient meets criteria for traditional use and preliminary preclinical support but requires well-designed Phase I and Phase II human trials to establish efficacy, safety, and effective dose ranges.
Preparation & Dosage
Traditional preparation
**Traditional Seed Decoction (Jamu/Ayurveda)**
Seeds boiled in water and consumed as a tea for constipation and eye ailments; no standardized volume established in modern literature.
**Seed Powder**
Ground seeds administered orally in traditional practice for dyspepsia, flatulence, and colic; no clinically validated dose range available.
**Methanolic/Ethanolic Extract (Research Grade)**
Prepared by Soxhlet extraction yielding approximately 4% w/w extract; used in preclinical studies at concentrations of 10–500 µg/mL in vitro.
**Ethyl Acetate Leaf Fraction (CtEA)**
8 mg/g dry weight quercetin equivalents; used at 0–25 µg/mL in antioxidant assays—no human dose established
Contains 106.8 ± 2..
**HPLC-Isolated Anthraquinones**
Purified chrysophanol, emodin, and obtusifolin used in mechanistic in vitro research; non-toxic at 10 µg/mL in sensitization studies.
**Standardization**
No commercial standardization percentage for anthraquinones or flavonoids has been established for Cassia tora supplements specifically; formulations should be distinguished from related Cassia senna products that have established anthraquinone standards.
**Timing Note**
Anthraquinone-based laxative preparations are conventionally taken at bedtime to allow 6–12 hours for onset of effect, consistent with Senna class pharmacokinetics.
Nutritional Profile
Cassia tora seeds and leaves are phytochemically rich rather than nutritionally significant as macronutrient sources. Key phytochemicals include anthraquinones—chrysophanol, emodin, rhein, aurantio-obtusin, chryso-obtusin, obtusin, and obtusifolin—along with flavonoids at up to 106.8 mg/g dry weight quercetin equivalents (ethyl acetate leaf fraction), polysaccharides, glycosides including cassiaside and torachrysone, alkaloids, saponins, and tannins. Phenolic content is substantial in leaf fractions, contributing to measured antioxidant capacity in ABTS and DPPH assays. Bioavailability of anthraquinone aglycones is influenced by gut microbiota-mediated hydrolysis of glycoside precursors, similar to the well-characterized metabolism of Senna glycosides; flavonoid bioavailability is enhanced by lipid co-ingestion and reduced by tannin co-precipitation. No formal proximate nutritional analysis (protein, fat, carbohydrate percentages) for standardized Cassia tora preparations is available in the cited literature.
How It Works
Mechanism of Action
Emodin and chrysophanol, the principal anthraquinone aglycones, act as primary antioxidants by directly scavenging superoxide and hydroxyl radicals and upregulating endogenous hepatic antioxidant enzymes—catalase, superoxide dismutase (SOD), and glutathione peroxidase (GPx)—thereby reducing oxidative DNA strand breaks as measured by the single-cell gel electrophoresis (Comet) assay in human lymphocytes. Anthraquinone glycosides stimulate large intestinal motility via irritant mechanisms on the colonic mucosa, increasing water and electrolyte secretion into the bowel lumen to soften stool and accelerate transit. Flavonoids including quercetin and kaempferol scavenge ABTS and DPPH radicals through hydrogen atom transfer and single electron transfer mechanisms, and stabilize erythrocyte membranes against osmotic and oxidative hemolysis by intercalating into lipid bilayers and chelating transition metals. The antimutagenic activity of anthraquinone aglycones is mediated by inhibition of cytochrome P450 bioactivation of pro-mutagens such as aflatoxin B1 and heterocyclic amines, reducing the formation of reactive electrophilic intermediates that would otherwise bind DNA.
Clinical Evidence
No human clinical trials for Cassia tora have been identified in the available literature, making it impossible to report controlled effect sizes, confidence intervals, or number-needed-to-treat statistics. Preclinical animal studies examined hypolipidemic outcomes in Wistar rats and hepatoprotective endpoints (enzyme activity) in ethanol-treated rats, and in vitro work assessed antioxidant capacity, antimutagenicity, and antimicrobial activity—none of which translates directly to human therapeutic claims. The compound-level mechanistic data is internally consistent and plausible, particularly for anthraquinone-mediated laxative and hepatoprotective effects, but must be considered hypothesis-generating rather than confirmatory. Confidence in clinical translation is low; regulatory bodies including the U.S. FDA and EMA have not approved Cassia tora extracts for any therapeutic indication, and practitioners should treat available data as preliminary.
Safety & Interactions
Human safety data for Cassia tora are absent from the published literature; all available toxicity assessments are preclinical, with extracts found non-toxic at 10 µg/mL in cell culture sensitization assays and protective rather than injurious to human lymphocytes at low concentrations in Comet assay protocols. By pharmacological class, anthraquinone-containing plants carry well-known risks including abdominal cramping, electrolyte imbalance (particularly hypokalemia), and melanosis coli with chronic laxative use—risks established for related anthraquinone plants (Senna, Rhubarb, Aloe) and likely applicable to Cassia tora but not specifically quantified for this species. Potential drug interactions include additive effects with other laxatives, diuretics (compounding hypokalemia risk), cardiac glycosides (potassium depletion potentiating toxicity), and anticoagulants, based on pharmacological class extrapolation. Cassia tora should be avoided during pregnancy due to stimulant laxative uterotonic risk consistent with the anthraquinone class, during lactation due to potential transfer of anthraquinone metabolites to breast milk, and in individuals with intestinal obstruction, inflammatory bowel disease, or known sensitivity to Cassia/Senna species; no maximum safe human dose has been formally established.
Synergy Stack
Hermetica Formulation Heuristic
Also Known As
Cassia tora L.Sickle PodCoffee PodSenna toraFoetid CassiaChakunda (Hindi)Ketepeng kecil (Indonesian)
Frequently Asked Questions
What are the main active compounds in Cassia tora seeds?
Cassia tora seeds are richest in anthraquinones including chrysophanol, emodin, rhein, aurantio-obtusin, chryso-obtusin, obtusin, and obtusifolin, along with cassiaside and torachrysone. These anthraquinone aglycones and glycosides are responsible for the plant's laxative, hepatoprotective, antioxidant, and antimutagenic activities documented in preclinical research. Flavonoids including quercetin, kaempferol, rutin, and epicatechin are found predominantly in the leaves at concentrations up to 106.8 mg/g dry weight in ethyl acetate extracts.
Is Cassia tora safe to use, and does it have side effects?
No formal human safety studies have been published for Cassia tora; cell culture data shows it is non-toxic at 10 µg/mL and protective against oxidative stress in human lymphocytes. However, as an anthraquinone-containing plant in the same family as Senna, chronic or high-dose use may cause abdominal cramping, diarrhea, hypokalemia, and with prolonged use, melanosis coli—risks established for the broader anthraquinone plant class. It should be avoided during pregnancy, lactation, and in individuals taking cardiac glycosides, diuretics, or other laxatives without medical supervision.
How is Cassia tora used in Indonesian Jamu medicine?
In Indonesian Jamu traditional medicine, Cassia tora seeds and leaves are used primarily for eye ailments—including inflammation and visual disturbances—and as a gentle laxative for constipation, reflecting the Jamu system's conceptual link between liver and eye health mediated by heat-clearing herbs. Preparations typically involve boiling seeds or leaves in water to produce a decoction consumed orally, or crushing leaves for topical skin applications. No standardized Jamu dose has been validated by modern clinical trials.
Does Cassia tora have clinical trial evidence supporting its use?
As of the current literature review, no human randomized controlled trials have been published for Cassia tora for any indication. Available evidence consists of in vitro studies (Comet assay, Ames test, antimicrobial disc diffusion) and small animal experiments (hepatotoxicity and hypolipidemic rat models) that provide mechanistic plausibility but cannot establish human efficacy or safety. The evidence score is rated preliminary; well-designed Phase I and II trials are needed before clinical recommendations can be made.
What is the difference between Cassia tora and Senna for constipation?
Both Cassia tora and Senna (Senna alexandrina) belong to the same Cassia/Senna botanical family and share anthraquinone glycosides as their primary laxative constituents, acting on the colon to stimulate peristalsis and increase luminal secretion. Senna is FDA-approved as an OTC laxative with well-established human clinical dosing (typically 12–50 mg sennosides per day for adults), whereas Cassia tora lacks any standardized or clinically validated human dose. Cassia tora is used regionally in traditional medicine systems but should not be substituted for standardized Senna preparations without professional guidance.
What specific flavonoids are found in Cassia tora leaf extracts, and how do they work as antioxidants?
Cassia tora leaf extracts contain quercetin, kaempferol, and epicatechin—flavonoids that provide approximately 106.8 ± 2.8 mg/g dry weight quercetin equivalents. These compounds scavenge ABTS radicals in a dose-dependent manner (0–25 µg/mL) and protect red blood cell membranes from oxidative damage caused by hydrogen peroxide, demonstrating potent free-radical neutralization.
Which plant part of Cassia tora is most potent for antioxidant benefits—seeds, leaves, or pods?
Cassia tora leaf extracts, particularly the ethyl acetate fraction (CtEA), demonstrate the most concentrated antioxidant activity with measurable flavonoid content and dose-dependent radical scavenging capacity. While seeds contain anthraquinone aglycones with different biological properties, the leaf fraction is specifically optimized for oxidative stress protection and membrane stabilization.
Can Cassia tora help protect the liver, and what is the mechanism?
Cassia tora contains anthraquinone aglycones that provide hepatoprotective benefits through mechanisms related to antioxidant and anti-inflammatory action. These compounds help shield liver cells from oxidative damage, supporting liver function and detoxification capacity, though the specific dosage and clinical efficacy require further human studies for definitive recommendations.
Explore the Full Encyclopedia
7,400+ ingredients researched, verified, and formulated for optimal synergy.
Browse IngredientsThese statements have not been evaluated by the Food and Drug Administration. This content is for informational purposes only and is not intended to diagnose, treat, cure, or prevent any disease.
hermetica-encyclopedia-canary-zzqv9k4w cassia-tora-cassia-tora-l curated by Hermetica Superfoods at ingredients.hermeticasuperfoods.com and licensed CC BY-NC-SA 4.0 (non-commercial share-alike, attribution required)
